These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26386450)

  • 21. The effects of educational background on Montreal Cognitive Assessment screening for vascular cognitive impairment, no dementia, caused by ischemic stroke.
    Wu Y; Wang M; Ren M; Xu W
    J Clin Neurosci; 2013 Oct; 20(10):1406-10. PubMed ID: 23891119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NINDS-Canadian stroke network vascular cognitive impairment neuropsychology protocols in Chinese.
    Wong A; Xiong YY; Wang D; Lin S; Chu WW; Kwan PW; Nyenhuis D; Black SE; Wong KS; Mok V
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):499-504. PubMed ID: 23250962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent validity of the short version of Montreal Cognitive Assessment (MoCA) for patients with stroke.
    Feng Y; Zhang J; Zhou Y; Chen B; Yin Y
    Sci Rep; 2021 Mar; 11(1):7204. PubMed ID: 33785809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of cognitive screening tools under different neuropsychological definitions for poststroke cognitive impairment.
    Chen X; Han Y; Zhou J; Ma M; Liu X
    Brain Behav; 2020 Aug; 10(8):e01671. PubMed ID: 32621406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease.
    Bezdicek O; Majerova V; Novak M; Nikolai T; Ruzicka E; Roth J
    Appl Neuropsychol Adult; 2013; 20(1):33-40. PubMed ID: 23373682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment.
    Memória CM; Yassuda MS; Nakano EY; Forlenza OV
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):34-40. PubMed ID: 22368034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment.
    Waldron-Perrine B; Axelrod BN
    Int J Geriatr Psychiatry; 2012 Nov; 27(11):1189-94. PubMed ID: 22228412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MoCA and MMSE as screeners for cognitive impairment in a heart failure population: a study with comprehensive neuropsychological testing.
    Hawkins MA; Gathright EC; Gunstad J; Dolansky MA; Redle JD; Josephson R; Moore SM; Hughes JW
    Heart Lung; 2014; 43(5):462-8. PubMed ID: 25035250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying cognitive impairment in heart failure: a review of screening measures.
    Davis KK; Allen JK
    Heart Lung; 2013; 42(2):92-7. PubMed ID: 23260324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computerized Cognitive Screen (CoCoSc): A Self-Administered Computerized Test for Screening for Cognitive Impairment in Community Social Centers.
    Wong A; Fong CH; Mok VC; Leung KT; Tong RK
    J Alzheimers Dis; 2017; 59(4):1299-1306. PubMed ID: 28731437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Diagnostic Utility of the NINDS-CSN Neuropsychological Battery in Memory Clinics.
    Xu X; Chan QL; Hilal S; Ikram MK; Venketasubramanian N; Tan BY; Dong Y; Chen CL; Collinson SL
    Dement Geriatr Cogn Dis Extra; 2016; 6(2):276-82. PubMed ID: 27504116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Accuracy of Cognitive Screening Instruments in Heart Failure: A Systematic Review.
    Cameron J; Kure CE; Pressler SJ; Ski CF; Clark AM; Thompson DR
    J Cardiovasc Nurs; 2016; 31(5):412-24. PubMed ID: 26164322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment.
    Swartz RH; Cayley ML; Lanctôt KL; Murray BJ; Smith EE; Sahlas DJ; Herrmann N; Cohen A; Thorpe KE
    Stroke; 2016 Mar; 47(3):807-13. PubMed ID: 26903584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of the Montreal Cognitive Assessment for traumatic brain injury patients with intracranial haemorrhage.
    Wong GK; Ngai K; Lam SW; Wong A; Mok V; Poon WS
    Brain Inj; 2013; 27(4):394-8. PubMed ID: 23473067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blunted responses to heart failure symptoms in adults with mild cognitive dysfunction.
    Lee CS; Gelow JM; Bidwell JT; Mudd JO; Green JK; Jurgens CY; Woodruff-Pak DS
    J Cardiovasc Nurs; 2013; 28(6):534-40. PubMed ID: 23013837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid cognitive screening of patients with substance use disorders.
    Copersino ML; Fals-Stewart W; Fitzmaurice G; Schretlen DJ; Sokoloff J; Weiss RD
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):337-44. PubMed ID: 19803633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric and cognitive symptoms in people with hypertension: An examination with the NINDS-CSN consensus protocol.
    Hsu YH; Lee M; Pan KL; Chen CY; Hung TH; Chen VC
    Appl Neuropsychol Adult; 2024; 31(1):39-47. PubMed ID: 34658278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.